Key Dates

Related Announcements

PAR-22-108 - Innovative ways to provide education on antimicrobial stewardship practices in animals (U01) Clinical Trial Not Allowed

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

This notice is to update the Scored Review Criteria for PAR-22-108 "Innovative ways to provide education on antimicrobial stewardship practices in animals (U01) Clinical Trial Not Allowed."

The following criterion currently reads:

Significance (20 Points)

Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?  

The following criterion should read:

Significance (20 Points)

Does the project address an important problem or a critical barrier to progress in the field? Is the prior research that serves as the key support for the proposed project rigorous? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?

Inquiries

Please direct all inquiries to:

Rene Vasquez
Grants Management Specialist
Office of Operations, Office of Finance Budget Acquisitions
Office of Acquisitions and Grants Services (OAGS)
Food and Drug Administration
Tel: 301-796-3546
Email: rene.vasquez@fda.hhs.gov